US Bancorp’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.3K | Sell |
2,009
-1,204
| -37% | -$15.8K | ﹤0.01% | 3065 |
|
|
2025
Q1 | $70.7K | Sell |
3,213
-96
| -3% | -$2.11K | ﹤0.01% | 2564 |
|
|
2024
Q4 | $88.4K | Sell |
3,309
-5,227
| -61% | -$140K | ﹤0.01% | 2453 |
|
|
2024
Q3 | $228K | Buy |
8,536
+8,468
| +12,453% | +$226K | ﹤0.01% | 1970 |
|
|
2024
Q2 | $1.23K | Hold |
68
| – | – | ﹤0.01% | 3761 |
|
|
2024
Q1 | $1.24K | Buy |
+68
| New | +$1.24K | ﹤0.01% | 3781 |
|
|
2023
Q4 | – | Sell |
-180
| Closed | -$1.03K | – | 4008 |
|
|
2023
Q3 | $1.03K | Sell |
180
-304
| -63% | -$1.74K | ﹤0.01% | 3740 |
|
|
2023
Q2 | $3.75K | Buy |
+484
| New | +$3.75K | ﹤0.01% | 3524 |
|
|
2023
Q1 | – | Sell |
-236
| Closed | -$2.11K | – | 4094 |
|
|
2022
Q4 | $2.11K | Buy |
+236
| New | +$2.11K | ﹤0.01% | 3740 |
|